【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, January 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, January 2013 9
2.2.1 MacroGenics Enters into Licensing Agreement with Gilead Sciences for DART Technology 9
2.2.2 Highmark to Acquire West Penn Allegheny Health System for $1.1 Billion 9
2.2.3 Allergan Commences Tender Offer to Acquire MAP Pharma, Migraine Drug Maker, for $958 Million 10
2.2.4 Tenet Healthcare Completed Private Placement of Notes Due 2021 for $850 Million 10
2.2.5 Baxter International to Acquire Rights to Hemophilia Compound OBI-1 and Related Assets for $700 Million 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, January 2013 12
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, January 2013 13
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, January 2013 14
3.1.1 Top M&A Deals in January 2013 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, August 2012–January 2013 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, January 2013 17
3.2.1 Top Equity Offering Deals in January 2013 18
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, August 2012 – January 2013 19
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, January 2013 20
3.3.1 Top PE/VC Deals in January 2013 21
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, January 2013 22
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, January 2013 23
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, August 2012 – January 2013 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, August 2012 – January 2013 26
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, January 2013 27
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, January 2013 27
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, August 2012 – January 2013 28
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), January 2013 29
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, January 2013 30
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), August 2012 – January 2013 31
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number of Deals, August 2012 – January 2013 32
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), August 2012 – January 2013 33
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), August 2012 – January 2013 34
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, January 2013 35
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, January 2013 35
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), January 2013 36
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, January 2013 37
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, January 2013 37
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, January 2013 37
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), August 2012 – January 2013 38
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), August 2012 – January 2013 39
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), August 2012 – January 2013 40
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), August 2012 – January 2013 42
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 43
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, January 2013 43
6.1.1 Oncology – Deals of the Month 44
6.2 Pharmaceuticals & Healthcare, Global, Immunology Deals, January 2013 45
6.2.1 Immunology – Deal of the Month 46
6.3 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, January 2013 47
6.3.1 Central Nervous System – Deals of the Month 48
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, January 2013 49
6.4.1 Metabolic Disorders – Deal of the Month 50
6.5 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, January 2013 51
6.5.1 Infectious Diseases – Deals of the Month 52
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, January 2013 53
6.6.1 Cardiovascular – Deal of the Month 54
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, January 2013 55
6.7.1 Gastrointestinal – Deals of the Month 56
7 Deal Summary by Geography 57
7.1 Pharmaceuticals & Healthcare, North America Deals, January 2013 57
7.1.1 North America – Deals of the Month 58
7.2 Pharmaceuticals & Healthcare, Europe, Deals, January 2013 60
7.2.1 Europe – Deals of the Month 61
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, January 2013 62
7.3.1 Asia-Pacific – Deals of the Month 63
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, January 2013 64
7.4.1 Rest of the World – Deals of the Month 65
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 66
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, August 2012 – January 2013 66
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, August 2012 – January 2013 67
9 Further Information 68
9.1 Methodology 68
9.2 About GlobalData 69
9.3 Contact Us 69
9.4 Disclosure information 69
9.5 Disclaimer 69
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：January 2013（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends for January 2013 in Pharmaceuticals
■ 発行日：2013年2月25日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160452
■ 調査対象地域：グローバル
- 世界の医療用電極市場：Global Medical Electrodes Market 2014-2018TechNavio forecasts The Global Medical Electrodes Market 2014-2018 with a CAGR of 12.20 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors t …
- PaaSの世界市場2015-2019PaaS is a category of cloud computing services that provides application development platform with a development tool hosted in the cloud and accessed through a web browser. The cloud resources are deployed and managed by cloud service providers while end-users have the liberty to use the service on a pay-per-use basis. With the PaaS solution, developers can build web applications without installi …
- ヘリコバクター・ピロリ菌検査の世界市場2015The report presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- 食品接触紙/板紙の世界市場2015-2019About Food Contact Paper and Board Food contact paper and board are used to package food products such as bakery goods, fruits, beverages, and take-out foods. On the basis of type, food contact paper and board can be categorized into two: non-poly-coated paper and board and poly-coated paper and board. While non-poly-coated paper and board are used to package dry food items, poly-coated paper and …
- 世界の映像（Video）管理ソフトウェア市場（2014-2018）TechNavio's analysts forecast the Global Video Management Software market to grow at a CAGR of 18.51 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing security concerns. The Global Video Management Software market has also been witnessing the increasing demand for high-quality images. However, the lack of standardization could pose a cha …
- 医療機器業界のM&A及び投資動向（月別）：June 2013Medical Equipment Monthly Deals Analysis: June 2013 - M&A and Investment Trends Summary GlobalData's “Medical Equipment Monthly Deals Analysis: June 2013 - M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings …
- パスタのグローバル市場（～2019）The industry report Global Pasta Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for pasta in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, …
- TurkeyのBitumen and Asphalt, Natural市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Turkey and its perspectives on the global market for bitumen and asphalt, natural. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on bitumen and asphalt, natural export/import operations in Turkey. The 2002-2012 …
- 企業モバイル管理2013（Enterprise Mobility 2013: BYOD, MDM, Big Data and Application Management）Key factors driving enterprise mobility today include Bring Your Own Device (BYOD), Mobile Device Management (MDM), and application management. Big Data also plays a role as corporations seek to better understand both their own employee’s as well as customer behaviors to optimize internal and external applications respectively. The trend towards BYOD is accelerating in which employees are allowed …
- 医療用移動補助具の世界市場2017-2021：車椅子、松葉杖、歩行器About Clinical Mobility Aids The global clinical mobility aids market includes both low-end and high-end products. Low-end mobility aids include canes, walkers, and crutches. These are, however, commonly used by the older adult population. On the other hand, high-end mobility aids such as manual wheelchairs, powered wheelchairs, and mobility scooters are preferred in clinics and hospitals to provi …
- 農業用ドローンの世界市場分析：製品別（固定翼、回転板、ハイブリッド）、用途別（フィールドマッピング、可変レートアプリケーション、作物スカウト）、セグメント予測 -2024The global agriculture drone market is expected to reach USD 3,770.0 million by 2024, according to a new report by Grand View Research, Inc. The increasing technological advancements in equipment and for enhancing the quality of the farming techniques have led to the increased implementation of agriculture drones in the market. Increasing automation in the agriculture process, owing to the labor c …
- 携帯電話用アクセサリーの世界市場：バッテリー、ヘッドフォン/イヤホン、ポータブルスピーカー、充電器、メモリーカード、保護ケース、パワーバンク、バッテリーケースThe global mobile phone accessories market was valued at $224.6 billion in 2018, and is estimated to reach $284.05 billion by 2026, growing at a CAGR of 3.1% from 2019 to 2026. Mobile phone plays an important role in the modern day to day life. Today, phones allow its users to access internet, take pictures, and listen to music, as well as feature as storage devices. The global mobile phone access …
- モバイルVASの世界市場About Mobile VAS Mobile value-added services (VAS) are user-friendly and convenient to use. These services help users save much time and effort. For instance, users can download music or videos, read news headlines, and book tickets at their convenience without the constraints of time and place. It becomes easier for end-users to search for a location, find directions, avail location-based adverti …
- アナトーの世界市場2018-2022About Annatto Annatto is an orange-red condiment and food coloring derived from the seeds of the achiote tree (Bixa orellana). It is often used to impart a yellow or orange color to foods, but sometimes also used for its flavor and aroma. Apart from food and beverage, annatto extracts and seeds also find applications in the textile, cosmetics, and pharmaceutical industries. Technavio’s analysts fo …
- 動脈石灰化：治療薬のグローバル治験動向（2014年下半期）Arterial Calcification Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Arterial Calcification Global Clinical Trials Review, H2, 2014" provides data on the Arterial Calcification clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arterial Calcification. It includes an overview of the trial numbers and …
